Skip to content
Riskpilot
← Back to search
Sign in
Sign in
Get full access
Euroform MediPharm AB
AB
Active
Org 5568728298
Vickerkullavägen 6, 591 45
Motala
Manufacture of other plastic products
·
NACE 2226
Est. 2011 · 14 years old
11 employees
Monitor
Share
Sweden
/
Companies
/
Manufacture of other plastic products
/
Euroform MediPharm AB
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
SEK millions
45M
34M
22M
11M
0M
2021: 36M
36M
2021
2022: 36M (0% vs 2021)
36M
0%
2022
2023: 32M (-11% vs 2022)
32M
-11%
2023
2024: 29M (-9% vs 2023)
29M
-9%
2024
2025: 32M (+10% vs 2024)
32M
+10%
2025
EBITDA
SEK millions
3M
0M
-2M
-4M
-7M
2021: -5M
-5M
2021
2022: -3M (+40% vs 2021)
-3M
+40%
2022
2023: 1M (+133% vs 2022)
1M
+133%
2023
2024: -2M (-300% vs 2023)
-2M
-300%
2024
2025: 1M (+150% vs 2024)
1M
+150%
2025
Income statement
SEK thousands
Item
2025
2024
2023
2022
2021
Revenue
31 974
28 526
31 899
35 802
35 608
Staff expenses
−7 069
—
—
—
—
EBITDA
611
−1 969
1 091
−2 573
−4 611
Depreciation & amort.
−748
−670
−878
−879
−6 942
EBIT
−138
−2 639
213
−3 452
−11 553
Net financials
118
237
272
−78
−390
Profit before tax
111
233
169
62
−33
Tax
−0
−0
−0
−0
−0
Net profit
111
233
169
62
−33
Balance sheet
SEK thousands
Item
2025
2024
2023
2022
2021
Total assets
20 996
20 519
24 143
24 763
27 589
Equity
14 256
14 145
13 912
13 743
13 681
Long-term debt
0
0
0
0
0
Short-term debt
5 990
5 625
9 481
9 400
11 783
Total debt
5 990
5 625
9 481
9 400
11 783
Financial ratios
5-year trend
EBITDA margin
1,9 %
This company
15,8 %
Market median
This company
Market median
88% below market
2021
2025
Equity ratio
67,9 %
This company
38,2 %
Market median
This company
Market median
78% above market
2021
2025
Return on equity
0,8 %
This company
18,4 %
Market median
This company
Market median
96% below market
2021
2025
Net profit margin
0,3 %
This company
8,1 %
Market median
This company
Market median
96% below market
2021
2025
Asset turnover
1,52×
This company
1,12×
Market median
This company
Market median
36% above market
2021
2025
Debt / equity
0,47×
This company
0,62×
Market median
This company
Market median
24% below market
2021
2025
Annual reports & filings
Annual report 2025
Filed via Bolagsverket / SCB · Period 2025-01-01 – 2025-12-31
View
PDF
Annual report 2024
Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
View
PDF
More on Euroform MediPharm AB
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
